Jiangsu Aosaikang Pharmaceutical Co., Ltd.

This early-stage study tests a new drug, ASKC202, alone or with another drug (ASK120067), in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. About 150 adu…